Crescent Biopharma, Inc. (CBIO) News
Track canonical SquawkNews coverage tagged to CBIO, Crescent Biopharma, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 6 indexed stories across 5 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Crescent Biopharma Grants Inducement Awards
Crescent Biopharma grants inducement awards
EQUITY | Aug 03, 2026, 11:30 AM UTC
L
CBIO - Crescent Biopharma Reports Second Quarter 2026 Financial Results and Recent Business Highlights
CBIO - Crescent Biopharma Reports Second Quarter 2026 Financial Results and Recent Business Highlights
EARNINGS | Jul 30, 2026, 11:35 AM UTC
L
Deal priced today • QTTB 6.03M share Secondary, priced at $18.25, by MSCO, JEFF, Cantor, OPCO & HCW • CBIO 8.1M share Spot Secondary, priced
Deal priced today • QTTB 6.03M share Secondary, priced at $18.25, by MSCO, JEFF, Cantor, OPCO & HCW • CBIO 8.1M share Spot Secondary, priced at $14.50, by JEFF, TD Cowen, GUGG, Cantor & LifeSci Deal postponed • TP (Ticke
REGULATION | Jul 15, 2026, 12:21 PM UTC
L
Crescent Biopharma files ordinary shares offering, no amount given
Crescent Biopharma files ordinary shares offering, no amount given
EQUITY | Jul 14, 2026, 08:23 PM UTC
L
CBIO Crescent Biopharma announces proposed public offering of ordinary shares and pre-funded warrants
CBIO Crescent Biopharma announces proposed public offering of ordinary shares and pre-funded warrants
EQUITY | Jul 14, 2026, 08:01 PM UTC
L
Crescent Biopharma Files Prospectus For Offering $500M Mixed Shelf
Crescent Biopharma Files Prospectus For Offering $500M Mixed Shelf
EQUITY | Jul 01, 2026, 08:19 PM UTC